An overview of statistical issues and methods of meta-analysis
Journal of Biopharmaceutical StatisticsPublished 1 January 1991
Eberhard Schmid, Gary G. Koch, Lisa M. LaVange
Citations55
SJR quartileQ2
SJR score0.56
SNIP0.78
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
This paper discusses issues that frequently arise in meta-analysis and gives an overview of the methods used, with particular attention to the use of fixed- and random-effects approaches.
Abstract
A meta-analysis is a statistical analysis of the data from some collection of studies in order to synthesize the results. In this paper we discuss issues that frequently arise in meta-analysis and give an overview of the methods used, with particular attention to the use of fixed- and random-effects approaches. The methods are then applied to two sample datasets.
Keywords
MedicineMathematicsDecision Sciences
Controlled Clinical TrialsMeta-analysis in clinical trials
39,316 Citations1986Rebecca DerSimonian, Nan M. Laird
This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
Journal of Educational StatisticsStatistical Methods for Meta-Analysis
10,479 Citations1988Stanley Wasserman, Larry V. Hedges +1 more
Methods of Meta-Analysis: Correcting Error and Bias in Research Findings
5,538 Citations2015Frank L. Schmidt, John E. Hunter
BiometricsThe Combination of Estimates from Different Experiments
5,203 Citations1954William G. Cochran
The Design and Analysis of Clinical Experiments
4,314 Citations1999Joseph L. Fleiss
Statistics in MedicineMethods for combining randomized clinical trials: Strengths and limitations
1,053 Citations1987David L. DeMets
Much can be learned from combining or pooling data but it must be done cautiously, and substantial scientific input is required as to what criteria must be met by each potential study.
BiometricsTesting for Qualitative Interactions between Treatment Effects and Patient Subsets
646 Citations1985Mitchell H. Gail, Richard Simon
A likelihood ratio test is developed to test for qualitative interactions and a non-crossover interaction arises when there is variation in the magnitude, but not in the direction, of treatment effects among subsets.
Statistics in MedicineInter‐study differences: How should they influence the interpretation and analysis of results?
108 Citations1987Kent R. Bailey
In determining the role inter-study variation should play in an overview analysis, it is important to consider three factors: which question one is trying to answer; the degree of similarity or dissimilarity of design, and the degree to which heterogeneity of outcomes can be explained.
New England Journal of MedicineA Randomized Study of Maintenance Therapy with Ranitidine to Prevent the Recurrence of Duodenal Ulcer
70 Citations1989Gary M. Van Deventer, Janet D. Elashoff +3 more
Patients who drank alcohol, smoked, had a history of ulcer disease, or had duodenal scarring or erosion at the time of entry into the study were at the greatest risk for recurrence and benefited the most from prophylactic ranitidine.
Statistics in MedicineAccumulating evidence from independent studies: What we can win and what we can lose
50 Citations1987Richard J. Light
In this discussion, some questions that can only be answered by examining a group of independent studies are outlined and some pitfalls that sometimes swamp the benefits the authors can gain from synthesis are discussed.
Journal of Clinical GastroenterologyComparison of Ranitidine and Cimetidine Ulcer Maintenance Therapy
38 Citations1987John H. Kurata, Gary G. Koch +1 more
The results from the analysis of seven clinical trials indicated that 8.4% fewer patients experienced an ulcer recurrence on ranitidine than on cimetidine, which indicated higher odds of recurrence versus nonrecurrence for cimetacid patients than ran itidine patients.
General Pharmacology The Vascular SystemUlcer disease; Investigation and basis for therapy
31 Citations1992
Twenty-four contributed chapters in four sections give medical researchers and practicing clinicians a review of the origins, presentations, therapies, and human investigation of ulcer disease.
Drug Information JournalStatistical Considerations in the Design, Analysis, and Interpretation of Comparative Clinical Studies
28 Citations1984Gary G. Koch, William A. Sollecito
Three general criteria are emphasized: clarity, comparability, and generalizability in terms of their implications to such considerations as scope of patient population, sample size, randomization, and covariance analysis.
Alimentary Pharmacology & TherapeuticsMaintenance therapy of duodenal ulcer with H<sub>2</sub>‐receptor antagonists—a meta‐analysis
23 Citations1990Robert H. Palmer, William O. Frank +1 more
Cimetidine, ranitidine, famotidine and nizatidine were all found to be superior to placebo to approximately the same extent when the results of the placebo‐controlled studies were expressed as odds ratios, a technique used to minimize differences in protocol design and patient populations among studies.
Journal of Clinical GastroenterologyPrevention of Duodenal Ulcer Occurrence
5 Citations1987T. D. Bolin, A. E. Davis +1 more
Life table estimates of duodenal ulcer recurrence during the 2-year period showed no significant difference between the two forms of treatment.